HUT73658A - Phenoxyphenylacetic acid derivatives - Google Patents
Phenoxyphenylacetic acid derivativesInfo
- Publication number
- HUT73658A HUT73658A HU9502725A HU9502725A HUT73658A HU T73658 A HUT73658 A HU T73658A HU 9502725 A HU9502725 A HU 9502725A HU 9502725 A HU9502725 A HU 9502725A HU T73658 A HUT73658 A HU T73658A
- Authority
- HU
- Hungary
- Prior art keywords
- acid derivatives
- phenoxyphenylacetic acid
- phenoxyphenylacetic
- derivatives
- vasospasm
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
- C07C59/70—Ethers of hydroxy-acetic acid, e.g. substitutes on the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3445593A | 1993-03-19 | 1993-03-19 | |
US19746794A | 1994-02-24 | 1994-02-24 |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9502725D0 HU9502725D0 (en) | 1995-11-28 |
HUT73658A true HUT73658A (en) | 1996-09-30 |
HU217028B HU217028B (hu) | 1999-11-29 |
Family
ID=26710968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9502725A HU217028B (hu) | 1993-03-19 | 1994-03-17 | Fenoxi-fenil-ecetsav-származékok |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0617001B1 (hu) |
JP (1) | JPH08508034A (hu) |
KR (1) | KR960700992A (hu) |
CN (1) | CN1119434A (hu) |
AT (1) | ATE189217T1 (hu) |
AU (1) | AU679710B2 (hu) |
CA (1) | CA2119051A1 (hu) |
CZ (1) | CZ233595A3 (hu) |
DE (1) | DE69422742T2 (hu) |
DK (1) | DK0617001T3 (hu) |
ES (1) | ES2141197T3 (hu) |
FI (1) | FI954404A0 (hu) |
GR (1) | GR3032643T3 (hu) |
HR (1) | HRP940179B1 (hu) |
HU (1) | HU217028B (hu) |
IL (1) | IL108944A0 (hu) |
NO (1) | NO953672L (hu) |
NZ (1) | NZ263414A (hu) |
PL (1) | PL175786B1 (hu) |
PT (1) | PT617001E (hu) |
RU (1) | RU2139273C1 (hu) |
SK (1) | SK114795A3 (hu) |
WO (1) | WO1994021590A1 (hu) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6124343A (en) * | 1919-01-27 | 2000-09-26 | Rhone-Poulenc Rorer Limited | Substituted phenyl compounds with a substituent having a thienyl ring |
US5514696A (en) * | 1992-05-06 | 1996-05-07 | Bristol-Myers Squibb Co. | Phenyl sulfonamide endothelin antagonists |
WO1996004905A1 (en) * | 1994-08-08 | 1996-02-22 | Merck & Co., Inc. | Phenoxyphenylacetic acid derivatives |
US5686478A (en) * | 1993-07-20 | 1997-11-11 | Merck & Co. Inc. | Endothelin antagonists |
US5612359A (en) * | 1994-08-26 | 1997-03-18 | Bristol-Myers Squibb Company | Substituted biphenyl isoxazole sulfonamides |
US5559135A (en) * | 1994-09-14 | 1996-09-24 | Merck & Co., Inc. | Endothelin antagonists bearing pyridyl amides |
US5538991A (en) * | 1994-09-14 | 1996-07-23 | Merck & Co., Inc. | Endothelin antagonists bearing 5-membered heterocyclic amides |
AU706940B2 (en) * | 1995-01-27 | 1999-07-01 | Rhone-Poulenc Rorer Limited | Substituted phenyl compounds as endothelin antagonists |
US5760038A (en) * | 1995-02-06 | 1998-06-02 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
US5780473A (en) * | 1995-02-06 | 1998-07-14 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
DE19527568A1 (de) * | 1995-07-28 | 1997-01-30 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
US5846990A (en) * | 1995-07-24 | 1998-12-08 | Bristol-Myers Squibb Co. | Substituted biphenyl isoxazole sulfonamides |
DE19528418A1 (de) * | 1995-08-02 | 1997-02-06 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
DE19530032A1 (de) * | 1995-08-16 | 1997-02-20 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
DE19537548A1 (de) * | 1995-10-09 | 1997-04-10 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
JPH09124620A (ja) | 1995-10-11 | 1997-05-13 | Bristol Myers Squibb Co | 置換ビフェニルスルホンアミドエンドセリン拮抗剤 |
AU703486B2 (en) * | 1995-12-12 | 1999-03-25 | Merck & Co., Inc. | Process for the preparation of an endothelin antagonist |
US5688974A (en) * | 1995-12-12 | 1997-11-18 | Merck & Co., Inc. | Process for the preparation of an endothelin antagonist |
US5977117A (en) * | 1996-01-05 | 1999-11-02 | Texas Biotechnology Corporation | Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin |
US5847008A (en) * | 1996-02-02 | 1998-12-08 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
US6090836A (en) * | 1996-02-02 | 2000-07-18 | Merck & Co., Inc. | Benzisoxazole-derived antidiabetic compounds |
US6020382A (en) * | 1996-02-02 | 2000-02-01 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
EP1011651B1 (en) * | 1996-02-02 | 2005-04-27 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
US5859051A (en) * | 1996-02-02 | 1999-01-12 | Merck & Co., Inc. | Antidiabetic agents |
HUP0002351A3 (en) | 1996-02-20 | 2001-10-29 | Bristol Myers Squibb Co | Methods for the preparation of biphenyl isoxazole sulfonamides, intermediates and process for preparing them |
US5856507A (en) * | 1997-01-21 | 1999-01-05 | Bristol-Myers Squibb Co. | Methods for the preparation of biphenyl isoxazole sulfonamides |
US5939446A (en) * | 1996-04-09 | 1999-08-17 | Bristol-Myers Squibb Co. | Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists |
GB9609641D0 (en) * | 1996-05-09 | 1996-07-10 | Pfizer Ltd | Compounds useful in therapy |
DE19653024A1 (de) * | 1996-12-19 | 1998-06-25 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
AU6187898A (en) * | 1997-01-30 | 1998-08-25 | Bristol-Myers Squibb Company | Method for preventing or treating low renin hypertension by administering an endothelin antagonist |
TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
DE19710831A1 (de) * | 1997-03-15 | 1998-09-17 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
ES2214734T3 (es) * | 1997-09-26 | 2004-09-16 | ABBOTT GMBH & CO. KG | Antagonista de la endotelina e inhibidor del sistema renina-angiotensina como preparado de combinacion. |
DE19743143A1 (de) | 1997-09-30 | 1999-04-01 | Knoll Ag | Pharmazeutische Kombinationspräparate |
GB9722287D0 (en) * | 1997-10-22 | 1997-12-17 | Pfizer Ltd | Compounds useful in therapy |
DE19747788A1 (de) | 1997-10-29 | 1999-05-06 | Basf Ag | Substituierte 2-(2'-Pyridyloxy)phenylessigsäureamide, ihre Herstellung und Verwendung, sowie sie enthaltende Mittel |
US6410554B1 (en) | 1998-03-23 | 2002-06-25 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
WO1999048530A1 (en) * | 1998-03-23 | 1999-09-30 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
NZ506877A (en) | 1998-03-31 | 2002-04-26 | Tanabe Seiyaku Co | Benzenesulfonamide compounds useful in treating dysuria |
US6017918A (en) * | 1998-08-06 | 2000-01-25 | Warner-Lambert Company | Phenyl glycine compounds and methods of treating atherosclerosis and restenosis |
US6284795B1 (en) | 1998-09-04 | 2001-09-04 | Warner-Lambert Company | Sulfonamide compounds and methods of treating atherosclerosis and restenosis |
KR20020004974A (ko) | 1999-03-19 | 2002-01-16 | 스티븐 비. 데이비스 | 비페닐 이속사졸 술폰아미드의 제조방법 |
AU1073001A (en) * | 1999-10-12 | 2001-04-23 | Basf Aktiengesellschaft | Method of identifying inhibitors of cdc25 |
DE60144284D1 (de) | 2000-11-01 | 2011-05-05 | Millennium Pharm Inc | Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung |
WO2002064094A2 (en) * | 2001-02-09 | 2002-08-22 | Merck & Co., Inc. | 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
NZ535603A (en) * | 2002-03-20 | 2007-10-26 | Metabolex Inc | Substituted phenylacetic acids |
US8614236B2 (en) | 2006-12-12 | 2013-12-24 | University Of Washington | Methods of treating pulmonary disease using acetazolamide and structurally related derivatives |
CN101042381B (zh) * | 2007-04-28 | 2014-01-08 | 长春迈灵生物工程有限公司 | 一种地舍平的检测方法 |
JP2013510145A (ja) * | 2009-11-09 | 2013-03-21 | メディヴィル・アクチエボラーグ | 1,3−オキサゾリジン化合物およびレニン阻害剤としてのそれらの使用方法 |
ES2533065T3 (es) | 2010-07-09 | 2015-04-07 | Pfizer Limited | Bencenosulfonamidas útiles como inhibidores de los canales de sodio |
CA2804877A1 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain |
CA2801032A1 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
ES2526981T3 (es) | 2010-07-12 | 2015-01-19 | Pfizer Limited | N-sulfonilbenzamidas como inhibidores de canales de sodio dependientes de voltaje |
CA2804716A1 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Chemical compounds |
WO2012007877A2 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Chemical compounds |
SG191040A1 (en) | 2010-12-23 | 2013-08-30 | Pfizer | Glucagon receptor modulators |
PE20140253A1 (es) | 2011-02-08 | 2014-03-09 | Pfizer | Moduladores del receptor de glucagon |
EP2734503B1 (en) | 2011-07-22 | 2015-09-16 | Pfizer Inc. | Quinolinyl glucagon receptor modulators |
WO2013088315A1 (en) | 2011-12-15 | 2013-06-20 | Pfizer Limited | Sulfonamide derivatives |
CN111825564B (zh) * | 2020-09-21 | 2020-12-29 | 西藏甘露藏药股份有限公司 | 一种从渣驯中提取的化合物、制备方法及其用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1408738A (fr) * | 1964-04-29 | 1965-08-20 | Nobel Bozel | Nouveaux dérivés de l'acide bis(hydroxy-4-phényl)-acétique |
US4748272A (en) * | 1986-08-01 | 1988-05-31 | Rorer Pharmaceutical Corp. | Phenoxyphenylacetates for use as potential modulators of arichidonic acid pathways |
JPS63122605A (ja) * | 1986-11-10 | 1988-05-26 | Tokuyama Soda Co Ltd | 除草剤組成物 |
-
1994
- 1994-03-10 DE DE69422742T patent/DE69422742T2/de not_active Expired - Fee Related
- 1994-03-10 AT AT94301728T patent/ATE189217T1/de not_active IP Right Cessation
- 1994-03-10 ES ES94301728T patent/ES2141197T3/es not_active Expired - Lifetime
- 1994-03-10 PT PT94301728T patent/PT617001E/pt unknown
- 1994-03-10 DK DK94301728T patent/DK0617001T3/da active
- 1994-03-10 EP EP94301728A patent/EP0617001B1/en not_active Expired - Lifetime
- 1994-03-11 IL IL10894494A patent/IL108944A0/xx unknown
- 1994-03-15 CA CA002119051A patent/CA2119051A1/en not_active Abandoned
- 1994-03-17 JP JP6521226A patent/JPH08508034A/ja not_active Withdrawn
- 1994-03-17 CN CN94191512A patent/CN1119434A/zh active Pending
- 1994-03-17 RU RU95121625A patent/RU2139273C1/ru active
- 1994-03-17 PL PL94310661A patent/PL175786B1/pl unknown
- 1994-03-17 WO PCT/US1994/002871 patent/WO1994021590A1/en not_active Application Discontinuation
- 1994-03-17 SK SK1147-95A patent/SK114795A3/sk unknown
- 1994-03-17 NZ NZ263414A patent/NZ263414A/en unknown
- 1994-03-17 CZ CZ952335A patent/CZ233595A3/cs unknown
- 1994-03-17 HU HU9502725A patent/HU217028B/hu not_active IP Right Cessation
- 1994-03-18 AU AU57878/94A patent/AU679710B2/en not_active Ceased
- 1994-03-18 HR HR940179A patent/HRP940179B1/xx not_active IP Right Cessation
-
1995
- 1995-09-18 KR KR1019950704018A patent/KR960700992A/ko not_active Application Discontinuation
- 1995-09-18 FI FI954404A patent/FI954404A0/fi unknown
- 1995-09-18 NO NO953672A patent/NO953672L/no not_active Application Discontinuation
-
2000
- 2000-02-11 GR GR20000400340T patent/GR3032643T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69422742D1 (de) | 2000-03-02 |
JPH08508034A (ja) | 1996-08-27 |
CN1119434A (zh) | 1996-03-27 |
HU9502725D0 (en) | 1995-11-28 |
ATE189217T1 (de) | 2000-02-15 |
RU2139273C1 (ru) | 1999-10-10 |
KR960700992A (ko) | 1996-02-24 |
ES2141197T3 (es) | 2000-03-16 |
PT617001E (pt) | 2000-06-30 |
HRP940179B1 (en) | 2000-10-31 |
EP0617001A1 (en) | 1994-09-28 |
NO953672D0 (no) | 1995-09-18 |
PL175786B1 (pl) | 1999-02-26 |
HRP940179A2 (en) | 1998-02-28 |
WO1994021590A1 (en) | 1994-09-29 |
FI954404A (fi) | 1995-09-18 |
CZ233595A3 (en) | 1996-01-17 |
NO953672L (no) | 1995-11-17 |
DK0617001T3 (da) | 2000-04-17 |
FI954404A0 (fi) | 1995-09-18 |
CA2119051A1 (en) | 1994-09-20 |
AU679710B2 (en) | 1997-07-10 |
EP0617001B1 (en) | 2000-01-26 |
IL108944A0 (en) | 1994-06-24 |
AU5787894A (en) | 1994-09-22 |
PL310661A1 (en) | 1995-12-27 |
SK114795A3 (en) | 1996-06-05 |
GR3032643T3 (en) | 2000-06-30 |
NZ263414A (en) | 1997-09-22 |
DE69422742T2 (de) | 2000-08-17 |
HU217028B (hu) | 1999-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3032643T3 (en) | Phenoxyphenylacetic acid derivatives. | |
MX9308191A (es) | Antagonistas de endotelina. | |
AP9701004A0 (en) | Low molecular weight bicyclic thrombin inhibitors. | |
CA2297911A1 (en) | Substituted 6-phenylphenanthridines | |
MY103352A (en) | Piperazinyl-heterocyclic compounds | |
RU92004368A (ru) | Замещенные пиримидины, способ их получения, фармацевтическая композиция | |
EP0539086A3 (en) | Condensed pyrimidine derivatives and their use as angiotensine ii antagonists | |
WO2000071516A3 (en) | INHIBITORS OF FACTOR Xa | |
CA2062837A1 (en) | 8-substituted purines as selective adenosine receptor agents | |
CH692199A8 (fr) | Composes pyridiques et compositions pharmaceutique | |
IL159897A0 (en) | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | |
ATE195948T1 (de) | Endothelinantagonisten | |
NZ337589A (en) | [1,4]diazepino[6,7,1-hi]indol-4-ones and there use in treating inflammatory diseases | |
DE69528711D1 (de) | Chinazolinen als inhibitoren des endothelin konvertierenden enzyme | |
PL326236A1 (en) | Novel compounds - derivatives of sulphonylpyrimidine exhibiting anticarcinogenous effect and method of obtaining them | |
CA2014062A1 (en) | Pyridine derivatives | |
HK1083492A1 (en) | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | |
MX12192A (es) | Composicion farmaceutica para reducir o impedir las arritmias | |
MX9704594A (es) | Peptidos heterociclicos de la ceto-arginina, como inhibidores de la trombina. | |
TH17364A (hu) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HMM4 | Cancellation of final prot. due to non-payment of fee |